PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.\', \'Collège Doctoral, Sorbonne Université, Paris, France.\', \'Infections Antimicrobials Modelling Evolution (IAME) UMR 1137, University of Paris, Paris, France.\', \'PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.\', \'Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.\', \'Virpath Laboratory, International Center of Research in Infectiology, INSERM U1111, CNRS-UMR 5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon University, Lyon, France.\', \'National Reference Center for Respiratory Viruses, Department of Virology, Infective Agents Institute, North Hospital Network, Lyon, France.\', \'INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2807/1560-7917.ES.2020.26.1.2001978
?:doi
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 33413741
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all